Find clinical trials for Endometrial Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer

Carcinoma

Ovarian Cancer

Breast Cancer

Triple Negative Breast Cancer

Ovarian Epithelial Carcinoma

Colorectal Cancer

Endometrial Cancer trials near Salt Lake City, UT, USA:

Abemaciclib and Letrozole to Treat Endometrial Cancer

letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...

Active, not recruiting

Endometrial Cancer

Drug: Letrozole

Drug: Abemaciclib

Phase 2

Gynecologic Oncology Group (GOG)

Salt Lake City, Utah, United States and 28 other locations

Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting

Endometrial Neoplasms

Drug: Doxorubicin

Drug: Paclitaxel

Phase 3

Eisai

Salt Lake City, Utah, United States and 168 other locations

PRO1184 for Advanced Solid Tumors (PRO1184-001)

This study will test the safety, including side effects, and determine the characteristics of a drug called PRO1184 in participants with solid tumors...

Enrolling

Hormone Receptor-positive/Her2 Negative Breast Cancer

High Grade Serous Ovarian Cancer

Drug: PRO1184 intravenous infusion of PRO1184

Drug: PRO1184

Phase 1, Phase 2

Genmab

West Valley City, Utah, United States of America and 31 other locations

A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma

in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...

Enrolling

Endometrial Adenocarcinoma

Platinum-resistant Ovarian Cancer

Diagnostic Test: OncoSignature

Drug: ACR-368

Phase 1, Phase 2

Acrivon Therapeutics

Salt Lake City, Utah, United States and 66 other locations

PRO1107 in Patients With Advanced Solid Tumors

and antitumor activity of PRO1107 in patients with advanced solid tumors. This study consists of 2 parts, Part A: dose escalation and dose l...

Enrolling

Endometrial Cancer

Non-small Cell Lung Cancer

Drug: PRO1107

Phase 1, Phase 2

Genmab

Salt Lake City, Utah, United States and 3 other locations

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

preliminary antitumor activity of NKT3447 in adult subjects with cyclin E1 (CCNE1) amplified ovarian cancer at the RDEs selected in Dose Es...

Enrolling

Solid Tumor

Ovarian Neoplasms

Drug: NKT3447

Phase 1

NiKang Therapeutics

West Valley City, Utah, United States of America and 7 other locations

A Study of PARG Inhibitor IDE161 in Participants with Advanced Solid Tumors

The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.

Enrolling

Endometrial Cancer

Breast Cancer

Drug: Pembrolizumab

Drug: IDE-161

Phase 1

Ideaya Biosciences

West Valley City, Utah, United States of America and 22 other locations

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors...

Enrolling

Uterine Cervical Neoplasms

Ovarian Neoplasms

Drug: LY4170156

Phase 1